Mechanisms of Diabetic Cardiomyopathy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 December 2024 | Viewed by 899
Special Issue Editor
Special Issue Information
Dear Colleagues,
When phosphodiesterase type 4 inhibitors and β-adrenoceptor agonists were found to be detrimental in chronic heart failure treatment, new treatments did not become available for a long time. This has changed with the advent of a neprilysin inhibitor/angiotensin receptor antagonist combination and, most recently, SGLT4 inhibitors. These new drug classes have also opened up avenues to more specifically treat cardiomyopathy as it occurs as a consequence of diabetes.
This Special Issue will welcome manuscripts exploring the pathophysiology and treatment of diabetic cardiomyopathy based on applicable cellular models, animal models and human isolated tissues; clinical studies in humans are also welcome if they provide mechanistic insight. Similarly, work on established drugs and drug targets and insight on potential new treatments will be welcome. Studies providing molecular and mechanistic insight will be particularly welcome.
Prof. Dr. Martin Michel
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- cardiomyopathy
- animal models
- novel treatments
- pathophyiology
- SGLT2 inhibitors
- neprilysin inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
